Media, Morphokinetics, and Mosaicism (3M)
Status
Conditions
Treatments
Details and patient eligibility
About
Embryonic aneuploidy is the underlying etiology for the majority of failed implantation and miscarriage. Preimplantation genetic screening (PGS) with transfer of a euploid embryo has been advocated as a strategy for increasing live birth rates with a single embryo transfer. Culturing embryos to the blastocyst stage for trophectoderm biopsy is a requirement for PGS. Several commercially-available single-step embryonic culture media with varying composition have been established for use in the IVF laboratory. Early reports have suggested differences in clinical outcomes, such as aneuploidy and miscarriage rates, with distinct culture media currently in standard use. However, there have been no clinical trials demonstrating the superiority of any one commercially-available culture media formulation. As a result, clinics use media with varying composition based upon familiarity and cost.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
All subjects planning blastocyst culture for preimplantation genetic screening (PGS) will be offered enrollment.
Antral Follicle Count (AFC) >8 Male and female partner > 18 years of age
Exclusion criteria
Female partner age >42 years of age Cleavage stage biopsy
Trial design
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal